Healthcare provider profile · identity verified

Muniba Chohan

Internal Medicine · SHEBOYGAN, WI · NPI 1063816031

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	688	163
Furosemide	Furosemide	634	107
Levothyroxine Sodium	Levothyroxine Sodium	555	83
Eliquis	Apixaban	539	81
Sertraline Hcl	Sertraline Hcl	485	90
Amlodipine Besylate	Amlodipine Besylate	303	83
Gabapentin	Gabapentin	268	67
Metoprolol Succinate	Metoprolol Succinate	246	67
Pantoprazole Sodium	Pantoprazole Sodium	228	81
Clopidogrel	Clopidogrel Bisulfate	218	49
Losartan Potassium	Losartan Potassium	191	43
Carvedilol	Carvedilol	181	44
Potassium Chloride	Potassium Chloride	181	59
Buspirone Hcl	Buspirone Hcl	180	38
Tamsulosin Hcl	Tamsulosin Hcl	178	44
Duloxetine Hcl	Duloxetine Hcl	159	33
Allopurinol	Allopurinol	157	37
Metoprolol Tartrate	Metoprolol Tartrate	152	48
Levetiracetam	Levetiracetam	142	38
Lisinopril	Lisinopril	128	42
Metformin Hcl	Metformin Hcl	126	39
Quetiapine Fumarate	Quetiapine Fumarate	123	29
Jardiance	Empagliflozin	117	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	117	25
Divalproex Sodium	Divalproex Sodium	115	30
Trazodone Hcl	Trazodone Hcl	109	32
Baclofen	Baclofen	108	22
Risperidone	Risperidone	97	12
Bumetanide	Bumetanide	94	21
Mirtazapine	Mirtazapine	94	34
Isosorbide Mononitrate Er	Isosorbide Mononitrate	93	22
Omeprazole	Omeprazole	93	32
Venlafaxine Hcl Er	Venlafaxine Hcl	93	15
Spironolactone	Spironolactone	89	26
Memantine Hcl	Memantine Hcl	87	22
Pravastatin Sodium	Pravastatin Sodium	87	23
Donepezil Hcl	Donepezil Hcl	82	22
Carbidopa-Levodopa	Carbidopa/Levodopa	79	17
Oseltamivir Phosphate	Oseltamivir Phosphate	75	74
Hydralazine Hcl	Hydralazine Hcl	74	27
Prednisone	Prednisone	70	19
Aripiprazole	Aripiprazole	67	15
Albuterol Sulfate Hfa	Albuterol Sulfate	61	40
Escitalopram Oxalate	Escitalopram Oxalate	61	22
Fluticasone Propionate	Fluticasone Propionate	61	27
Xarelto	Rivaroxaban	61	13
Entresto	Sacubitril/Valsartan	59	suppressed
Finasteride	Finasteride	57	16
Ondansetron Hcl	Ondansetron Hcl	56	39
Arexvy	Rsvpref3 Antigen/As01e/Pf	54	54
Fluoxetine Hcl	Fluoxetine Hcl	53	15
Midodrine Hcl	Midodrine Hcl	53	29
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	52	14
Amiodarone Hcl	Amiodarone Hcl	49	15
Torsemide	Torsemide	47	12
Hydrochlorothiazide	Hydrochlorothiazide	46	11
Montelukast Sodium	Montelukast Sodium	46	15
Alendronate Sodium	Alendronate Sodium	45	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	44	22
Trulicity	Dulaglutide	44	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	43	15
Tizanidine Hcl	Tizanidine Hcl	42	suppressed
Divalproex Sodium Er	Divalproex Sodium	41	11
Simvastatin	Simvastatin	40	14
Linzess	Linaclotide	39	14
Insulin Lispro Kwikpen U-100	Insulin Lispro	38	16
Benztropine Mesylate	Benztropine Mesylate	36	suppressed
Latanoprost	Latanoprost	36	11
Doxazosin Mesylate	Doxazosin Mesylate	35	suppressed
Lactulose	Lactulose	35	13
Myrbetriq	Mirabegron	35	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	35	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	14
Digoxin	Digoxin	31	suppressed
Glipizide	Glipizide	31	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Bupropion Xl	Bupropion Hcl	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Famotidine	Famotidine	29	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	23
Olanzapine	Olanzapine	28	suppressed
Methenamine Hippurate	Methenamine Hippurate	27	suppressed
Nystatin	Nystatin	27	21
Hydroxyzine Hcl	Hydroxyzine Hcl	26	14
Metformin Hcl Er	Metformin Hcl	26	suppressed
Cephalexin	Cephalexin	25	17
Brilinta	Ticagrelor	24	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	24	suppressed
Lamotrigine	Lamotrigine	24	11
Hydrocortisone	Hydrocortisone	23	16
Primidone	Primidone	23	suppressed
Sucralfate	Sucralfate	23	suppressed
Exemestane	Exemestane	22	suppressed
Calcium Acetate	Calcium Acetate	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	14
Incruse Ellipta	Umeclidinium Bromide	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Insulin Aspart Flexpen	Insulin Aspart	20	12
Lantus	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	14
Acetic Acid	Acetic Acid	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	17
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	19	suppressed
Humalog	Insulin Lispro	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Atenolol	Atenolol	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Spiriva Handihaler	Tiotropium Bromide	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Gemtesa	Vibegron	16	suppressed
Lubiprostone	Lubiprostone	16	suppressed
Methimazole	Methimazole	16	suppressed
Nystop	Nystatin	16	15
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	16	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	16	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Budesonide	Budesonide	14	suppressed
Anastrozole	Anastrozole	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	13	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	13	11
Nitroglycerin	Nitroglycerin	13	12
Novolog Flexpen	Insulin Aspart	13	suppressed
Topiramate	Topiramate	13	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	12	12
Creon	Lipase/Protease/Amylase	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	11
Folic Acid	Folic Acid	12	suppressed
Glatopa	Glatiramer Acetate	12	suppressed
Lurasidone Hcl	Lurasidone Hcl	12	suppressed
Pentoxifylline	Pentoxifylline	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Dalfampridine Er	Dalfampridine	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Klayesta	Nystatin	11	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error